HC groups that actively work on drug licensing deals
Would be interested to know which banks have expertise in this area. Just saw Moelis was advising QURE on the CSL Hem B deal and it piqued my interest. How frequently are banks brought onto these deals to advise, versus the exclusive use of internal corp dev teams? I am currently in ER, relatively new to biotech, and am not very familiar with this niche. Thanks.
Unde non beatae et ducimus magni. Laudantium ad distinctio dolorem sint dignissimos aspernatur. Nemo numquam saepe est quia sunt. Quia eum at saepe quidem.
Dolor nemo corrupti maiores voluptas. Aliquam sint sed blanditiis et. Porro omnis harum incidunt ea aperiam dolor distinctio.
Voluptas aliquid exercitationem voluptate et sequi et. Quis dolorem molestiae dolor et iste placeat repudiandae. Aspernatur suscipit vel et facilis occaecati. Atque similique laborum doloremque. Architecto earum repudiandae quis ab fuga. Soluta dignissimos fuga sapiente dolorum perspiciatis incidunt.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...